A/PR8 infection increased the number of BALF cells that were significantly reduced by 1NMPP1 treatment (Fig 2E), suggesting that TrkA inhibition could reduce the degree of virus-induced lung inflammation. This evidence concerns the gene NTRK1 and infection.